Assessing efgartigimod dosing patterns and Myasthenia Gravis Activities of Daily Living outcomes in clinical practice: results from a large patient support program database.

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

http://www.ncbi.nlm.nih.gov/pubmed/42598382

A Gordon Smith; Cynthia Qi; Deborah Gelinas; Gil I Wolfe; Jamie Aldridge; Kristin Heerlein; Mai Sato; Matthew Jefferson; Mihir Dhingra; Pushpa Narayanaswami; Ratna Bhavaraju-Sanka; Rohit R Menon

Aug 15, 2026